Edit
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Interventional Oncology Market to reach USD XX million by 2028.

Global Interventional Oncology Market Size study, By Product (Ablation, Particle Embolization, Support Devices), and Regional Forecasts 2022-2028

Product Code: HLSDT-11662196
Publish Date: 30-08-2022
Page: 200

Global Interventional Oncology Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028.

The Interventional Oncology can be defined as a cancer treatment procedure with minimally invasive techniques in the management of cancer. In Interventional procedure an oncologist performs diagnostic procedures, such as colonoscopies or endoscopies, X-ray, ultrasound, computed tomography (CT), magnetic resonance imaging (MRI) to enable targeted and precise treatment of cancer tumours. The growing penetration of Cancer worldwide and increasing demand for minimally invasive treatment procedures as well as recent collaboration activities from leading market players are factors that are accelerating the global market demand. For instance, according to World Cancer Research Fund International estimates – as of 2020, around 18.1 million cancer cases were estimated worldwide. Out of these, 9.3 million cases were reported in men and around 8.8 million reported in women. Breast and lung cancers were the most common cancers worldwide, accounting for 12.5% (2.26 million) and 12.2% (2.20 million) of the total number of new cases diagnosed in 2020. Furthermore, leading market players are working towards strategic partnerships and collaborations to develop interventional oncology solutions. For instance, in July 2021, Medical technology firm Terumo Europe and University Medical Centre Utrecht (UMCU) entered in a memorandum of understanding (MoU) to extend their partnership in the field of oncology. Also, growing number of R&D activities towards new cancer therapeutics as well as rising healthcare infrastructure in emerging economies are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, inadequate distribution of funds for the research purpose, and earth of skilled professionals impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Interventional Oncology Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing number of research and development activities and presence of leading cancer care centers in the region. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as growing healthcare sector and increasing incidences of cancer cases in the region, would create lucrative growth prospects for the global Interventional Oncology Market across the Asia Pacific region.

Major market players included in this report are:
Alpinion Medical Systems Co. Ltd.
AngioDynamics
Boston Scientific Corporation
Hologic, Inc.
Medtronic Plc.
Merit Medical
Profound Medical
Siemens Healthineers
Teleflex Incorporated
Terumo Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product
Ablation
Particle Embolization
Support Devices
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Interventional Oncology Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Global Interventional Oncology Market, by Region, 2020-2028 (USD Million)
1.2.2. Global Interventional Oncology Market, by Product, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Interventional Oncology Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Interventional Oncology Market Dynamics
3.1. Interventional Oncology Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growing penetration of Cancer worldwide.
3.1.1.2. Increasing demand for minimally invasive treatment procedures.
3.1.1.3. Recent collaboration activities from leading market players.
3.1.2. Market Challenges
3.1.2.1. Inadequate distribution of funds for the research purpose
3.1.2.2. Dearth of skilled professionals.
3.1.3. Market Opportunities
3.1.3.1. Growing number of R&D activities towards new cancer therapeutics.
3.1.3.2. Rising healthcare infrastructure in emerging economies.
Chapter 4. Global Interventional Oncology Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Interventional Oncology Market, by Product
6.1. Market Snapshot
6.2. Global Interventional Oncology Market by Product, Performance – Potential Analysis
6.3. Global Interventional Oncology Market Estimates & Forecasts by Product 2018-2028 (USD Million)
6.4. Interventional Oncology Market, Sub Segment Analysis
6.4.1. Ablation
6.4.2. Particle Embolization
6.4.3. Support Devices
Chapter 7. Global Interventional Oncology Market, Regional Analysis
7.1. Interventional Oncology Market, Regional Market Snapshot
7.2. North America Interventional Oncology Market
7.2.1. U.S. Interventional Oncology Market
7.2.1.1. Product estimates & forecasts, 2018-2028
7.2.2. Canada Interventional Oncology Market
7.3. Europe Interventional Oncology Market Snapshot
7.3.1. U.K. Interventional Oncology Market
7.3.2. Germany Interventional Oncology Market
7.3.3. France Interventional Oncology Market
7.3.4. Spain Interventional Oncology Market
7.3.5. Italy Interventional Oncology Market
7.3.6. Rest of Europe Interventional Oncology Market
7.4. Asia-Pacific Interventional Oncology Market Snapshot
7.4.1. China Interventional Oncology Market
7.4.2. India Interventional Oncology Market
7.4.3. Japan Interventional Oncology Market
7.4.4. Australia Interventional Oncology Market
7.4.5. South Korea Interventional Oncology Market
7.4.6. Rest of Asia Pacific Interventional Oncology Market
7.5. Latin America Interventional Oncology Market Snapshot
7.5.1. Brazil Interventional Oncology Market
7.5.2. Mexico Interventional Oncology Market
7.6. Rest of The World Interventional Oncology Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Alpinion Medical Systems Co. Ltd.
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. AngioDynamics
8.2.3. Boston Scientific Corporation
8.2.4. Hologic, Inc.
8.2.5. Medtronic Plc.
8.2.6. Merit Medical
8.2.7. Profound Medical
8.2.8. Siemens Healthineers
8.2.9. Teleflex Incorporated
8.2.10. Terumo Corporation
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

The study of the market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geographies to provide a better regional outlook. In the report, country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. Our analysts contact company executives, managers, key opinion leaders, and industry experts. This enables our analyst to derive the closest possible figures without any major deviations in the actual number.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now